icon
icon
icon
icon
Upgrade
icon

GSK's (GSK.US) experimental drug Depemokimab showed positive results in a trial for nasal polyps

AInvestMonday, Oct 14, 2024 4:30 am ET
1min read

GlaxoSmithKline's (GSK.US) experimental drug for a common nasal condition showed positive results in two late-stage trials, boosting the British drugmaker's pipeline.

Depemokimab helped reduce nasal congestion and the size of polyps in patients with chronic sinusitis with nasal polyps, a common disease that affects up to 4% of the population, GSK said. About 40% of patients with the condition are not controlled, the company said in a statement on Monday.

Shares of GSK rose about 1% before the U.S. market opened on Monday. The stock has risen 2.3% since the beginning of the year.

Depemokimab is seen as a key part of GSK's growth over the next few years, with the company hoping to launch the drug for multiple diseases between 2026 and 2027. The company expects Depemokimab to generate annual sales of up to £3bn (US$3.9bn).

The drug is a super-long-acting injection that can be given to patients every six months. Depemokimab has also been shown to help prevent severe asthma attacks. GSK will present the full results of the drug's trials for chronic sinusitis with nasal polyps at a scientific meeting.

Comments

Post
No Comment Yet
Disclaimer: the above is a summary showing certain market information. AInvest is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from a third party source. Communications displaying market prices, data and other information available in this post are meant for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.
You Can Understand News Better with AI.
Whats the News impact on stock market?
Its impact is
fork
logo
AInvest
Aime Coplilot
Invest Smarter With AI Power.
Open App